A comparative study of the efficacy and safety of intralesional measles, mumps, and rubella vaccine versus intralesional vitamin D3 for the treatment of warts in children

被引:8
作者
Mohta, Alpana [1 ]
Kushwaha, Ramesh Kumar [1 ]
Gautam, Umesh [1 ]
Sharma, Pritee [1 ]
Nyati, Asha [1 ]
Jain, Suresh Kumar [1 ]
机构
[1] GMC, Dept Dermatol Venereol & Leprosy, Kota, Rajasthan, India
关键词
extragenital warts; immunotherapy; measles; mumps; and rubella; pediatric patients; vitamin D3; RECALCITRANT CUTANEOUS WARTS; OPEN-LABEL; SKIN-TEST; IMMUNOTHERAPY; CANDIDA; INJECTION; ANTIGENS;
D O I
10.1111/pde.14280
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background Intralesional vitamin D3 has recently emerged as a new treatment for cutaneous warts. The use of the measles, mumps, and rubella (MMR) vaccine for this purpose is an established modality. However, relevant data on the efficacy of either the MMR vaccine or vitamin D3 as immunotherapy for cutaneous warts in the pediatric population are limited. Objectives To compare the efficacy and safety of intralesional injections of MMR vaccine to intralesional injections of vitamin D3 in children aged 8-16 years with multiple warts. Methods A total of 74 children were randomly allocated into two groups. Group A patients received intralesional MMR vaccine into the largest wart, and group B received intralesional vitamin D3 into the largest wart. The injections were repeated every 4 weeks until clearance or for a maximum of three treatments. After the last injection, children were followed up every 2 weeks for 3 months, and at the sixth month, a final clinical assessment was conducted. Results Of 74 children, 60 completed the study, with 30 children in each group. Complete clearance of the injected wart was observed in 26 (86.67%) patients in the MMR group (group A) and 23 (76.7%) patients in the vitamin D3 group (group B). Distant warts cleared in 23 (76.7%) patients in group A compared to 20 (66.6%) patients in group B. There was no significant difference between groups. No recurrence was seen in group A, whereas two (6.6%) children in group B exhibited recurrence in the ensuing 6-month follow-up. The most common adverse events were injection site pain and swelling. Conclusion Both intralesional MMR and vitamin D3 are safe, generally well-tolerated, and equally effective in children for the treatment of cutaneous warts.
引用
收藏
页码:853 / 859
页数:7
相关论文
共 36 条
[1]   Quadrivalent Human Papillomavirus Vaccination: A Promising Treatment for Recalcitrant Cutaneous Warts in Children [J].
Abeck, Dietrich ;
Foelster-Holst, Regina .
ACTA DERMATO-VENEREOLOGICA, 2015, 95 (08) :1017-1019
[2]   Intralesional vitamin D3 versus intralesional purified protein derivative in treatment of multiple warts: A comparative clinical and immunological study [J].
Abou-Taleb, Doaa A. E. ;
Abou-Taleb, Heba A. ;
El-Badawy, Omnia ;
Ahmed, Asmaa O. ;
Hassan, Alaa EL-din Thabiet ;
Awad, Sara M. .
DERMATOLOGIC THERAPY, 2019, 32 (05)
[3]  
Agrawal Chesta, 2018, Indian Dermatol Online J, V9, P389, DOI 10.4103/idoj.IDOJ_111_18
[4]   Intralesional Vitamin D Injection May Be an Effective Treatment Option for Warts [J].
Aktas, Habibullah ;
Ergin, Can ;
Demir, Betul ;
Ekiz, Ozlem .
JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2016, 20 (02) :118-122
[5]  
Antaya RJ, 2019, J DRUGS DERMATOL, V18, P368
[6]   Human papillomavirus vaccines and the potential for cross-protection between related HPV types [J].
Ault, Kevin A. .
GYNECOLOGIC ONCOLOGY, 2007, 107 (02) :S31-S33
[7]  
Awal Guneet, 2018, J Clin Aesthet Dermatol, V11, P15
[8]   Natural Course of Cutaneous Warts Among Primary Schoolchildren: A Prospective Cohort Study [J].
Bruggink, Sjoerd C. ;
Eekhof, Just A. H. ;
Egberts, Paulette F. ;
van Blijswijk, Sophie C. E. ;
Assendelft, Willem J. J. ;
Gussekloo, Jacobijn .
ANNALS OF FAMILY MEDICINE, 2013, 11 (05) :437-441
[9]   The Efficacy and Safety of Intralesional Immunotherapy with Measles, Mumps, Rubella Virus Vaccine for the Treatment of Common Warts in Adults [J].
Chauhan, Pushpinder Singh ;
Mahajan, Vikram K. ;
Mehta, Karaninder Singh ;
Rawat, Ritu ;
Sharma, Vikas .
INDIAN DERMATOLOGY ONLINE JOURNAL, 2019, 10 (01) :19-26
[10]   Immunotherapy for recalcitrant warts in children using intralesional mumps or Candida antigens [J].
Clifton, MM ;
Johnson, SM ;
Roberson, PK ;
Kincannon, J ;
Horn, TD .
PEDIATRIC DERMATOLOGY, 2003, 20 (03) :268-271